JPH03200714A - Composition for oral cavity application - Google Patents
Composition for oral cavity applicationInfo
- Publication number
- JPH03200714A JPH03200714A JP34170489A JP34170489A JPH03200714A JP H03200714 A JPH03200714 A JP H03200714A JP 34170489 A JP34170489 A JP 34170489A JP 34170489 A JP34170489 A JP 34170489A JP H03200714 A JPH03200714 A JP H03200714A
- Authority
- JP
- Japan
- Prior art keywords
- glucose
- fatty acid
- composition
- sodium
- acid ester
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 30
- 210000000214 mouth Anatomy 0.000 title claims abstract 3
- -1 glucose fatty acid ester Chemical class 0.000 claims abstract description 42
- 239000000194 fatty acid Substances 0.000 claims abstract description 40
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 39
- 229930195729 fatty acid Natural products 0.000 claims abstract description 39
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 34
- 239000008103 glucose Substances 0.000 claims abstract description 34
- 150000003839 salts Chemical class 0.000 claims abstract description 18
- 239000002253 acid Substances 0.000 claims abstract description 16
- 125000002252 acyl group Chemical group 0.000 claims abstract description 5
- 125000004432 carbon atom Chemical group C* 0.000 claims description 7
- 239000000606 toothpaste Substances 0.000 abstract description 19
- 235000019640 taste Nutrition 0.000 abstract description 18
- 229940034610 toothpaste Drugs 0.000 abstract description 18
- 239000004094 surface-active agent Substances 0.000 abstract description 10
- 239000007788 liquid Substances 0.000 abstract description 6
- 239000011230 binding agent Substances 0.000 abstract description 2
- 235000003599 food sweetener Nutrition 0.000 abstract description 2
- 229940071085 lauroyl glutamate Drugs 0.000 abstract description 2
- 239000002324 mouth wash Substances 0.000 abstract description 2
- 229940051866 mouthwash Drugs 0.000 abstract description 2
- LXLKSDZYPAOYRF-SSPAHAAFSA-N octanoic acid;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal Chemical compound CCCCCCCC(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O LXLKSDZYPAOYRF-SSPAHAAFSA-N 0.000 abstract description 2
- 239000003765 sweetening agent Substances 0.000 abstract description 2
- 239000000551 dentifrice Substances 0.000 abstract 2
- 239000012459 cleaning agent Substances 0.000 abstract 1
- 238000013329 compounding Methods 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 239000003906 humectant Substances 0.000 abstract 1
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical class [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 abstract 1
- 210000003254 palate Anatomy 0.000 abstract 1
- 150000004665 fatty acids Chemical class 0.000 description 13
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 12
- 238000005187 foaming Methods 0.000 description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 7
- 239000004615 ingredient Substances 0.000 description 7
- 229940085605 saccharin sodium Drugs 0.000 description 7
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 6
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 6
- 239000000600 sorbitol Substances 0.000 description 6
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 5
- 235000001014 amino acid Nutrition 0.000 description 5
- 239000001768 carboxy methyl cellulose Substances 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 4
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 235000019658 bitter taste Nutrition 0.000 description 3
- 229910000019 calcium carbonate Inorganic materials 0.000 description 3
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 description 3
- 235000010418 carrageenan Nutrition 0.000 description 3
- 239000000679 carrageenan Substances 0.000 description 3
- 229920001525 carrageenan Polymers 0.000 description 3
- 229940113118 carrageenan Drugs 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 239000004088 foaming agent Substances 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 210000002200 mouth mucosa Anatomy 0.000 description 3
- 229920000728 polyester Polymers 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 3
- 235000012239 silicon dioxide Nutrition 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 229940083542 sodium Drugs 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 3
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 2
- 239000004367 Lipase Substances 0.000 description 2
- 102000004882 Lipase Human genes 0.000 description 2
- 108090001060 Lipase Proteins 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- WINXNKPZLFISPD-UHFFFAOYSA-M Saccharin sodium Chemical compound [Na+].C1=CC=C2C(=O)[N-]S(=O)(=O)C2=C1 WINXNKPZLFISPD-UHFFFAOYSA-M 0.000 description 2
- FTCGZXFZNUEELT-BURFUSLBSA-N [(2r,3r,4s,5r)-2,3,4,5-tetrahydroxy-6-oxohexyl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O FTCGZXFZNUEELT-BURFUSLBSA-N 0.000 description 2
- 125000005907 alkyl ester group Chemical group 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 2
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 description 2
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Chemical compound CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 235000019700 dicalcium phosphate Nutrition 0.000 description 2
- 229940095079 dicalcium phosphate anhydrous Drugs 0.000 description 2
- NAYZMSNLBRPCBX-SSPAHAAFSA-N dodecanoic acid;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.CCCCCCCCCCCC(O)=O NAYZMSNLBRPCBX-SSPAHAAFSA-N 0.000 description 2
- 235000019421 lipase Nutrition 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 2
- 235000010413 sodium alginate Nutrition 0.000 description 2
- 239000000661 sodium alginate Substances 0.000 description 2
- 229940005550 sodium alginate Drugs 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- 241000894007 species Species 0.000 description 2
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 2
- 238000005809 transesterification reaction Methods 0.000 description 2
- 239000004711 α-olefin Substances 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- NGOZDSMNMIRDFP-UHFFFAOYSA-N 2-[methyl(tetradecanoyl)amino]acetic acid Chemical compound CCCCCCCCCCCCCC(=O)N(C)CC(O)=O NGOZDSMNMIRDFP-UHFFFAOYSA-N 0.000 description 1
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 1
- AXCXHFKZHDEKTP-NSCUHMNNSA-N 4-methoxycinnamaldehyde Chemical compound COC1=CC=C(\C=C\C=O)C=C1 AXCXHFKZHDEKTP-NSCUHMNNSA-N 0.000 description 1
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 239000004604 Blowing Agent Substances 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 239000005973 Carvone Substances 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- BACYUWVYYTXETD-UHFFFAOYSA-N N-Lauroylsarcosine Chemical compound CCCCCCCCCCCC(=O)N(C)CC(O)=O BACYUWVYYTXETD-UHFFFAOYSA-N 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- GYDJEQRTZSCIOI-UHFFFAOYSA-N Tranexamic acid Chemical compound NCC1CCC(C(O)=O)CC1 GYDJEQRTZSCIOI-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- HEGOZZGDTGYRGM-OIMNJJJWSA-N [(2r,3r,4s,5r)-2,3,4,5-tetrahydroxy-6-oxohexyl] octanoate Chemical compound CCCCCCCC(=O)OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O HEGOZZGDTGYRGM-OIMNJJJWSA-N 0.000 description 1
- DXZLYYNUEYZDIU-UHFFFAOYSA-N [O-2].[Al+3].C(C(C)O)O.[O-2].[O-2].[Al+3] Chemical compound [O-2].[Al+3].C(C(C)O)O.[O-2].[O-2].[Al+3] DXZLYYNUEYZDIU-UHFFFAOYSA-N 0.000 description 1
- 239000003082 abrasive agent Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 125000004442 acylamino group Chemical group 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 229910000323 aluminium silicate Inorganic materials 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 229940011037 anethole Drugs 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 229940000635 beta-alanine Drugs 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229960003563 calcium carbonate Drugs 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229940043256 calcium pyrophosphate Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- QMXNBMYMWQZNKH-SSPAHAAFSA-N decanoic acid;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal Chemical compound CCCCCCCCCC(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O QMXNBMYMWQZNKH-SSPAHAAFSA-N 0.000 description 1
- 235000019821 dicalcium diphosphate Nutrition 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- QGGZBXOADPVUPN-UHFFFAOYSA-N dihydrochalcone Chemical compound C=1C=CC=CC=1C(=O)CCC1=CC=CC=C1 QGGZBXOADPVUPN-UHFFFAOYSA-N 0.000 description 1
- PXLWOFBAEVGBOA-UHFFFAOYSA-N dihydrochalcone Natural products OC1C(O)C(O)C(CO)OC1C1=C(O)C=CC(C(=O)CC(O)C=2C=CC(O)=CC=2)=C1O PXLWOFBAEVGBOA-UHFFFAOYSA-N 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical class O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 125000000400 lauroyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 229940105132 myristate Drugs 0.000 description 1
- 229940070800 myristoyl glutamate Drugs 0.000 description 1
- 125000001419 myristoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940070782 myristoyl sarcosinate Drugs 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 125000002811 oleoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000003016 phosphoric acids Chemical class 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229940068918 polyethylene glycol 400 Drugs 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 229940043230 sarcosine Drugs 0.000 description 1
- 108700004121 sarkosyl Proteins 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 235000015424 sodium Nutrition 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- 229940045944 sodium lauroyl glutamate Drugs 0.000 description 1
- AQMNWCRSESPIJM-UHFFFAOYSA-M sodium metaphosphate Chemical compound [Na+].[O-]P(=O)=O AQMNWCRSESPIJM-UHFFFAOYSA-M 0.000 description 1
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 125000003696 stearoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229940117986 sulfobetaine Drugs 0.000 description 1
- 150000008054 sulfonate salts Chemical class 0.000 description 1
- 150000003871 sulfonates Chemical class 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- YUOWTJMRMWQJDA-UHFFFAOYSA-J tin(iv) fluoride Chemical compound [F-].[F-].[F-].[F-].[Sn+4] YUOWTJMRMWQJDA-UHFFFAOYSA-J 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- 150000005691 triesters Chemical class 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- XPFJYKARVSSRHE-UHFFFAOYSA-K trisodium;2-hydroxypropane-1,2,3-tricarboxylate;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound [Na+].[Na+].[Na+].OC(=O)CC(O)(C(O)=O)CC(O)=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O XPFJYKARVSSRHE-UHFFFAOYSA-K 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は、発泡性及び味が良好で、使用感に優れた口腔
用組成物に関する。DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] The present invention relates to an oral composition that has good foaming properties, good taste, and has an excellent feeling of use.
〔従来の技術及び発明が解決しようとする課題〕口腔用
組威物には、その清浄力を高め、更に使用した際に心地
良い使用感を付与するため、界面活性剤が配合されてい
る。このような口腔用組成物に用いられる界面活性剤に
は、使用時に口腔用組成物を日中に分散する効果、口腔
用組成物中の薬効成分の分散や浸透を促進する効果1発
泡による口腔内への泡の拡がり効果等に加え、日中で使
用するために味、匂いが良好で、しかも口腔粘膜に対す
る作用が極めて穏和である等の高い安全性が要求される
。[Prior Art and Problems to be Solved by the Invention] Oral compositions contain surfactants in order to enhance their cleaning power and provide a pleasant feeling when used. Surfactants used in such oral compositions have the effect of dispersing the oral composition during the day when used, and the effect of promoting the dispersion and penetration of medicinal ingredients in the oral composition. In addition to the effect of foam spreading inward, high safety is required, such as good taste and odor for use during the day, and extremely mild action on the oral mucosa.
従来、口腔用組成物に用いられる界面活性剤としては、
アルキル硫酸エステル塩、脂肪酸モノグリセリド硫酸エ
ステル塩、α−オレフィンスルホン酸塩、N−アシルザ
ルコシン塩等のアニオン界面活性剤やショ糖脂肪酸エス
テル等の非イオン界面活性剤が用いられている。Conventionally, surfactants used in oral compositions include:
Anionic surfactants such as alkyl sulfate ester salts, fatty acid monoglyceride sulfate ester salts, α-olefin sulfonates, N-acyl sarcosine salts, and nonionic surfactants such as sucrose fatty acid esters are used.
しかし、アルキル硫酸エステル塩、脂肪酸モノグリセリ
ド硫酸エステル塩、α−オレフィンスルホン酸塩には、
程度の差こそあれ、いずれも口腔粘膜に対する刺激が認
められ、更にそれ自体不快な味と匂いを有している。ま
た、N−アシルザルコシン塩は、味は改善されているも
のの、口腔粘膜剥離の問題がある。更に、ショ糖脂肪酸
エステルは、非常に高い安全性を示す反面、発泡性及び
味に問題がある。However, alkyl sulfate salts, fatty acid monoglyceride sulfate salts, α-olefin sulfonate salts,
All of them are found to be irritating to the oral mucosa, to varying degrees, and each has an unpleasant taste and odor. Furthermore, although the taste of N-acyl sarcosine salts is improved, there is a problem of oral mucosal peeling. Furthermore, although sucrose fatty acid esters exhibit very high safety, they have problems with foaming properties and taste.
また従来、グルコース脂肪酸エステルを歯磨の発泡剤と
して使用することも知られている(国際公開W0 88
/10147号公報)が、グルコース脂肪酸エステルは
発泡性がなお十分でなく、特にこの公報に記載されてい
るグルコース脂肪酸エステルはモノエステル含量が少な
く、ジエステル、トリ以上のポリエステルがかなりの量
で混在しているため、味、発泡性等の点で問題がある。It has also been known to use glucose fatty acid ester as a foaming agent for toothpaste (International Publication W088
However, the foaming properties of glucose fatty acid esters are still insufficient, and in particular, the glucose fatty acid esters described in this publication have a low monoester content and contain a considerable amount of diesters, tri- or higher polyesters. Because of this, there are problems with taste, foaming properties, etc.
このため、口腔用組成物に使用されて、清浄力を高める
という界面活性剤本来の機能を有することに加え、安全
性が高く、発泡性及び味の良好な界面活性剤が求められ
ている。Therefore, there is a need for a surfactant that can be used in oral compositions and not only has the original function of a surfactant to increase cleaning power, but also has high safety, foaming properties, and good taste.
〔課題を解決するための手段及び作用〕本発明者は、上
記要望に応えるため鋭意検討を重ねた結果、アシル基の
炭素数が8〜14であるグルコース脂肪酸エステルを組
成物全体の0.5重量%以下のN−アシルアミノ酸塩に
併用することが有効であることを知見した。[Means and effects for solving the problem] As a result of extensive studies in order to meet the above-mentioned needs, the inventors of the present invention have determined that glucose fatty acid ester having an acyl group having 8 to 14 carbon atoms should be added to 0.5 of the total composition. It has been found that it is effective to use N-acylamino acid salts in combination with weight percent or less.
即ち、N−アシルアミノ酸塩は、上述したように味はよ
いが、多量に使用すると口腔粘膜剥離の問題があるため
、通常その配合量が0.5%(重量%、以下同じ)以下
に制限されている。しかし、N−アシルアミノ酸塩は0
.5%程度の配合量では発泡性が劣るものであるが、上
記グルコース脂肪酸エステルをN−アシルアミノ酸塩に
併用すること、またこの場合、好ましくはグルコース脂
肪酸エステルとして1分子中にアシル基を1個有するモ
ノエステル(なお、本発明において、モノエステルとは
モノエステル含量が90重量%以上のものを意味する)
を使用することにより、N−アシルアミノ酸塩が0.5
%以下の少量であっても、両者が相乗的に作用して優れ
た発泡性を与えることを知見すると共に、これら両活性
剤の併用系は味が良く、かつN−アシルアミノ酸塩の使
用量を0.5%以下とすることにより高い安全性を有す
ることを見い出し、本発明をなすに至ったものである。That is, as mentioned above, N-acylamino acid salts have a good taste, but if used in large quantities, there is a problem of oral mucosal detachment, so the amount of N-acyl amino acid salts is usually limited to 0.5% (wt%, same hereinafter) or less. has been done. However, N-acyl amino acid salt is 0
.. Although the foaming properties are poor when the amount is about 5%, it is preferable to use the glucose fatty acid ester in combination with the N-acylamino acid salt, and in this case, it is preferable that the glucose fatty acid ester has one acyl group in one molecule. (In the present invention, monoester means a monoester having a monoester content of 90% by weight or more)
By using N-acyl amino acid salt, 0.5
It has been found that even in small amounts of less than %, the two act synergistically to provide excellent foaming properties, and the combined system of these two active agents has a good taste, and the amount of N-acylamino acid salt used can be reduced. It was discovered that high safety can be achieved by setting the content to 0.5% or less, leading to the present invention.
以下、本発明につき更に詳しく説明する。The present invention will be explained in more detail below.
本発明に係る口腔用組成物は、練歯磨、潤製歯磨、液状
歯磨、洗口剤、義歯用洗浄剤等として調製、適用される
もので、グルコース脂肪酸エステルとN−アシルアミノ
酸塩とを併用してなるものである。The oral composition according to the present invention is prepared and applied as a toothpaste, a moist toothpaste, a liquid toothpaste, a mouthwash, a denture cleaner, etc., and is a combination of a glucose fatty acid ester and an N-acylamino acid salt. This is what happens.
ここで、本発明に使用されるグルコース脂肪酸エステル
としては、グルコースと炭素数8〜14の脂肪酸又はそ
の低級アルキルエステル等の脂肪酸誘導体とから得られ
るものである。炭素数が8より小さいもの及び14より
大きいものは味や発泡性が劣り、好ましくない。Here, the glucose fatty acid ester used in the present invention is obtained from glucose and a fatty acid having 8 to 14 carbon atoms or a fatty acid derivative such as a lower alkyl ester thereof. Those with a carbon number smaller than 8 and those larger than 14 are undesirable because they have poor taste and foaming properties.
この場合、原料グルコースとしては、天然に得られるグ
ルコースやとうもろこし、じゃがいもなどの澱粉その他
の多糖類を酸や酵素で加水分解し。In this case, the raw material glucose is obtained by hydrolyzing naturally occurring glucose, starch from corn, potato, etc., and other polysaccharides using acids and enzymes.
これを脱色、精製したものを用いることができる。It can be used after being decolorized and purified.
このようなものとしては、JASで規定されている結晶
ブドウ糖、粉末ブドウ糖、粒状ブドウ糖などが例示され
る。Examples of such substances include crystalline glucose, powdered glucose, and granular glucose defined by JAS.
一方5脂肪酸としては、炭素数8〜14のものであれば
天然2合成、飽和、不飽和、直鎖1分枝。On the other hand, 5-fatty acids include those with 8 to 14 carbon atoms, which include natural 2-synthetic, saturated, unsaturated, and linear 1-branched fatty acids.
単一、混合などの別なく好適に用いることができる。更
に、脂肪酸の低級エステルとしては、上記脂肪酸のメチ
ル、エチル、プロピルなどの炭素数1〜8を有するアル
キルエステルを用いることができ、また脂肪酸のハロゲ
ン化物を原料とすることもできる。They can be suitably used regardless of whether they are used singly or as a mixture. Further, as the lower ester of the fatty acid, an alkyl ester having 1 to 8 carbon atoms such as methyl, ethyl, and propyl of the above-mentioned fatty acids can be used, and a halogenated fatty acid can also be used as the raw material.
グルコース脂肪酸エステルは、これらの原料を用いて、
リパーゼ等によるエステル合成、例えば原料油脂とグル
コースとのエステル交換反応、脂肪酸の低級アルコール
エステルとグルコースとのエステル交換反応、脂肪酸と
グルコースとのエステル合成などの方法、更に脂肪酸ク
ロライドとグルコースとを用いた合成法、その他種々の
公知の方法で合成することが好ましい。Glucose fatty acid ester is produced using these raw materials.
Methods such as ester synthesis using lipase, for example, transesterification reaction between raw oil and fat and glucose, transesterification reaction between lower alcohol esters of fatty acids and glucose, ester synthesis between fatty acids and glucose, and further using fatty acid chloride and glucose. It is preferable to synthesize by a synthetic method or various other known methods.
この場合、本発明において、グルコース脂肪酸エステル
としては、モノエステル含量が90%以上、特に95%
以上のグルコース脂肪酸エステルを用いることが、上述
した本発明の目的を達する上で好ましい。また、トリエ
ステル以上のポリエステル含量が1%以下、特に0.5
%以下であることがより好ましいが、上述した公知法で
はいずれもモノエステル含量が少なく、トリ以上のポリ
エステル含量の多いエステルが製造されるため。In this case, in the present invention, the glucose fatty acid ester has a monoester content of 90% or more, particularly 95%.
It is preferable to use the above glucose fatty acid esters in order to achieve the above-mentioned object of the present invention. In addition, the polyester content of triester or higher is 1% or less, especially 0.5
% or less, but the above-mentioned known methods all produce esters with a low monoester content and a high tri- or higher polyester content.
モノエステルを得る場合は、合成後の分画、単離に手間
を要することがある。従って、この点でモノエステルの
製造には、先に本出願人が特願平1−210495号で
提案した耐熱性リパーゼを用いる方法が好適に採用され
る。When obtaining a monoester, it may take time and effort to perform fractionation and isolation after synthesis. Therefore, in this respect, the method using heat-stable lipase, which was previously proposed by the present applicant in Japanese Patent Application No. 1-210495, is preferably adopted for the production of monoester.
なお、グルコース脂肪酸モノエステルとしては、グルコ
ースの6位のOH基がエステル化されている下記式(H
のものが好ましい。In addition, as glucose fatty acid monoester, the following formula (H
Preferably.
(式中Rは、炭素数8〜14の飽和又は不飽和脂肪酸の
残基を示す。〉
このようなグルコース脂肪酸モノエステルとしては、グ
ルコースモノカプリレート、グルコースモノカプレート
、グルコースモノラウレート、グルコースモノミリステ
ート、グルコースそノウンデシレネート、グルコースモ
ノ−2−エチルオクタネートなどが例示される。(In the formula, R represents a residue of a saturated or unsaturated fatty acid having 8 to 14 carbon atoms.) Examples of such glucose fatty acid monoester include glucose monocaprylate, glucose monocaprate, glucose monolaurate, and glucose monolaurate. Examples include myristate, glucose sonoundecylenate, glucose mono-2-ethyl octanate, and the like.
なお、本発明は、上記グルコース脂肪酸エステルの1種
を単独で用いてもよく、2種以上を組み合わせて用いる
こともできる。In addition, in the present invention, one type of the above-mentioned glucose fatty acid ester may be used alone, or two or more types may be used in combination.
グルコース脂肪酸エステルの配合量は種々選定すること
ができるが、組成物全体の0.1〜10%、特に0.5
〜5%とすることが好ましい。The amount of glucose fatty acid ester blended can be selected in various ways, but it is 0.1 to 10% of the total composition, especially 0.5%.
It is preferable to set it to 5%.
一方、本発明に用いられるN−アシルアミノ酸塩として
は、N−長鎖アシルアミノ酸塩、特に炭素数8〜18の
飽和もしくは不飽和のアシル基を有するもの、具体的に
はラウロイル基、ミリストイル基、バルミトイル基、ス
テアロイル基、オレオイル基、ヤシ油脂肪酸残基、硬化
牛脂脂肪酸残基、或いはこれらの混合脂肪酸残基などが
好適に用いられる。また、そのアミノ酸の種類に何ら制
限はないが、グルタミン酸、ザルコシン、N−メチル−
β−アラニン等を単独又は2種以上を併用して用いるこ
とが好ましい。例示すると、N−ラウロイルグルタメー
ト、N−ミリストイルグルタメート、N−ラウロイルザ
ルコシネート、N−ミリストイルザルコシネート、N−
ラウロイル−N−メチル−βアラニネートのナトリウム
塩又はカリウム塩等が挙げられ、これらの1種又は2種
以上を組み合わせて用いることができる。N−アシルア
ミノ酸塩の配合量は0.5%以下である。On the other hand, the N-acylamino acid salts used in the present invention include N-long chain acylamino acid salts, especially those having a saturated or unsaturated acyl group having 8 to 18 carbon atoms, specifically lauroyl group, myristoyl group. , a valmitoyl group, a stearoyl group, an oleoyl group, a coconut oil fatty acid residue, a hydrogenated beef tallow fatty acid residue, or a mixed fatty acid residue thereof, etc. are preferably used. In addition, there are no restrictions on the types of amino acids, but glutamic acid, sarcosine, N-methyl-
It is preferable to use β-alanine or the like alone or in combination of two or more. To illustrate, N-lauroyl glutamate, N-myristoyl glutamate, N-lauroyl sarcosinate, N-myristoyl sarcosinate, N-
Examples include sodium salt or potassium salt of lauroyl-N-methyl-β alaninate, and these salts can be used alone or in combination of two or more. The amount of N-acyl amino acid salt added is 0.5% or less.
0.5%を越えて使用すると口腔粘膜の剥離を生じるこ
とがあり、好ましくない。If it is used in an amount exceeding 0.5%, it may cause peeling of the oral mucosa, which is not preferable.
本発明の口腔用組成物には、上記成分に加え、その種類
等に応じた種々の成分を配合することができる。In addition to the above-mentioned components, the oral composition of the present invention can contain various components depending on the type thereof.
例えば、上記グルコース脂肪酸エステルの効果を損なわ
ない範囲で他の界面活性剤、例えば他のアニオン界面活
性剤や、脂肪酸モノグリセリド。For example, other surfactants, such as other anionic surfactants and fatty acid monoglycerides, as long as they do not impair the effects of the glucose fatty acid ester.
脂肪酸アルカノールアミド、ポリオキシエチレンソルビ
タン脂肪酸エステル、ポリオキシエチレン硬化ヒマシ油
、シヨ糖脂肪酸エステル等の非イオン界面活性剤、アル
キルベタイン、イミダゾリニウムベタイン、アルキルス
ルホベタイン等の両性界面活性剤、アルキルアミンオキ
シド等の半極性界面活性剤などが挙げられ、これらの1
種又は2種以上と組み合わせて用いることができる。Nonionic surfactants such as fatty acid alkanolamide, polyoxyethylene sorbitan fatty acid ester, polyoxyethylene hydrogenated castor oil, sucrose fatty acid ester, amphoteric surfactants such as alkyl betaine, imidazolinium betaine, alkyl sulfobetaine, alkylamines Examples include semipolar surfactants such as oxides, and these 1
It can be used as a species or in combination of two or more species.
更に、歯磨類には、第2リン酸カルシウム、炭酸カルシ
ウム、ピロリン酸カルシウム、不溶性メタリン酸ナトリ
ウム、水酸化アルミニウム、無水ケイ酸等の研磨剤、グ
リセリン、ソルビット、プロピレングリコール、ポリエ
チレングリコール等の湿潤剤、カルボキシメチルセルロ
ースナトリウム、カラギーナン、アルギン酸ナトリウム
、ビーガム、ヒドロキシエチルセルロース、キサンタン
ガム、ポリアクリル酸ナトリウム等の粘結剤、サッカリ
ンナトリウム、グリチルリチン塩類、ステビオサイド、
パラメトキシシンナミックアルデヒド、ネオヘスベリジ
ルジヒドロカルコン、ペリラルチン等の甘味剤、メント
ール、カルボン、アネトール等の香料などが使用され、
更に必要に応じてモノフルオロリン酸ナトリウム、フッ
化ナトリウム、フッ化錫等のフッ化物、トラネキサム酸
。Furthermore, toothpastes contain abrasives such as dicalcium phosphate, calcium carbonate, calcium pyrophosphate, insoluble sodium metaphosphate, aluminum hydroxide, and silicic anhydride, wetting agents such as glycerin, sorbitol, propylene glycol, and polyethylene glycol, and carboxymethyl cellulose. Sodium, carrageenan, sodium alginate, vegum, hydroxyethyl cellulose, xanthan gum, binders such as sodium polyacrylate, sodium saccharin, glycyrrhizin salts, stevioside,
Sweeteners such as paramethoxycinnamic aldehyde, neohesberidyl dihydrochalcone, perilartine, and flavoring agents such as menthol, carvone, and anethole are used.
Furthermore, if necessary, fluorides such as sodium monofluorophosphate, sodium fluoride, and tin fluoride, and tranexamic acid.
ε−アミノカプロン酸、アラントイネート等の抗炎症剤
、リン酸ナトリウム等のリン酸化合物などの薬効成分が
適宜使用される。Medicinal ingredients such as anti-inflammatory agents such as ε-aminocaproic acid and allantoinate, and phosphoric acid compounds such as sodium phosphate are used as appropriate.
また、他の口腔用組成物も同様に常用成分を適宜配合し
得、これら口腔用組成物は常法に従って調製することが
できる。Further, other oral compositions may similarly be formulated with commonly used ingredients, and these oral compositions may be prepared according to conventional methods.
本発明に係る口腔用組成物は、上記グルコース脂肪酸エ
ステルを0.5%以下の使用量でN−アシルアミノ酸塩
と併用したことにより、優れた洗浄効果を与えると共に
、味、発泡性が優れ、使用感が良好である上、安全性が
高いものである。The oral composition according to the present invention uses the glucose fatty acid ester in an amount of 0.5% or less in combination with an N-acylamino acid salt, thereby providing an excellent cleaning effect, as well as excellent taste and foaming properties. Not only is it comfortable to use, but it is also highly safe.
次に、実験例により本発明の効果を具体的に説明する。Next, the effects of the present invention will be specifically explained using experimental examples.
〔実験例1〕
第1表に示す発泡剤(界面活性剤)を用い、下記処方の
練歯磨組成物を常法により調製した。これらの練歯磨組
成物の発泡性及び味を下記の方法で評価した。結果を第
1表に示す。[Experimental Example 1] Using the foaming agents (surfactants) shown in Table 1, a toothpaste composition having the following formulation was prepared by a conventional method. The foamability and taste of these toothpaste compositions were evaluated by the following methods. The results are shown in Table 1.
隷書歴盟或修麩友 (単位%)
第2リン酸カルシウム 45.0無水
ケイ酸 3.0カルボキ
シメチルセルロースナトリウム 0.8カラギーナン
0.2ソルビツト液
26.0プロピレングリコー
ル 3.0サツカリンナトリウム
0.2香 料
1.0発泡剤
第1表に示す置針
100.0
゛ び の1 ゛
上記処方により調製された練歯磨組成物を用い、よく訓
練された専門パネラ−5名による歯磨試験を行ない、以
下の評価基準により、発泡性及び味を評価した。Reisho history alliance or Shufuyu (unit: %)
Dibasic calcium phosphate 45.0 Silicic acid anhydride 3.0 Sodium carboxymethyl cellulose 0.8 Carrageenan 0.2 Sorbiturate solution
26.0 Propylene glycol 3.0 Saccharin sodium
0.2 fragrance
1.0 blowing agent
Using the toothpaste composition prepared according to the above formulation, a toothpaste test was conducted by five well-trained expert panelists, and the foaming property was evaluated according to the following evaluation criteria. and taste was evaluated.
発泡性評価基準
O:良好な発泡性あり
0:適度な発泡性あり
Δ:やや発泡性あり
×:はとんど泡立たない
味の評価基準
O:良好(苦味なし)
△:やや苦味あり
×:苦味が強く使用に耐えない
第1表に示す如く、グルコース脂肪酸エステルとN−ア
シルアミノ酸塩とを併用することにより、味に悪い影響
を与えることなく、発泡性を大きく向上することが認め
られた。Foamability evaluation criteria O: Good foamability 0: Moderate foamability Δ: Slight foamability ×: Hardly foamy taste evaluation criteria O: Good (no bitterness) △: Slightly bitterness ×: Strong bitterness and unbearable use As shown in Table 1, the combined use of glucose fatty acid ester and N-acylamino acid salt was found to significantly improve foaming properties without adversely affecting taste. .
〔実験例2〕
第2表に示す発泡剤(界面活性剤)を用いた以外は、実
験例1と同様の処方の練歯磨組成物を調製した。これら
の練歯磨組成物の発泡性と味を実験例1と同様の基準で
評価した。結果を第2表に示す。[Experimental Example 2] A toothpaste composition having the same formulation as Experimental Example 1 was prepared except that the foaming agent (surfactant) shown in Table 2 was used. The foamability and taste of these toothpaste compositions were evaluated using the same criteria as in Experimental Example 1. The results are shown in Table 2.
第2表に示す如く、グルコース脂肪酸エステルとN−ア
シルアミノ酸塩とを併用した練歯磨組成物はいずれも良
好な発泡性と味を示した。As shown in Table 2, all of the toothpaste compositions using a combination of glucose fatty acid ester and N-acylamino acid salt exhibited good foaming properties and taste.
以下、実施例を示すが、本発明は下記の実施例に制限さ
れるものではない。Examples will be shown below, but the present invention is not limited to the following examples.
〔実施例1〕 練歯磨
成 分 重量%
水酸化アルミニウム 40.0無水
ケイ酸 2.0プロピ
レングリコール 3・0ソルビツト
液 15.0グリセリン
15.0アルギン酸ナトリ
ウム 1.0サツカリンナトリウ
ム 0.2グルコース−6−モノ
ラウレート1.5N−ラウロイルグルタミン酸ナトリウ
ム 0.5香 料
10防腐剤 微量
討
100.0
〔実施例2〕 練歯磨
成分
アルミノシリケート
グリセリン
ソルビット液
ポリエチレングリコール400
カルボキシメチルセルロースナトリウムサッカリンナト
リウム
グルコース−6−モノカプレート
N−ラウロイルザルコシンナトリウム
香 料
色 素
精製水
〔実施例3〕 練歯磨
炭酸カルシウム(重質)
災酸カルシウム(軽質)
プロピレングリコール
ソルビット液
重量%
20、0
15.0
40.0
4.0
1.2
0.2
1.0
0.5
1.0
微量
残量
30゜
15゜
3゜
30゜
カルボキシメチルセルロースナトリウムサッカリンナト
リウム
トラネキサム酸
グルコース−6−モノカプリレート
N−ミリストイルメチル−β−アラニンナトリウム
香 料
防腐剤
1.0
微量
グルコース−6−モノカプレート
N−ラウロイルザルコシンナトリウム
アラントインクロルヒドロキシアルミニウム香 料
防腐剤
〔実施例5〕 練歯磨
1.0
0.5
0、 1
1.0
微量
〔実施例4〕 練歯磨
成分
第2リン酸カルシウム
無水ケイ酸
酸化アルミニウム
プロピレングリコール
ソルビット液
カルボキシメチルセルロースナトリウムカラギーナンサ
ッ
カリンナトリウム
重量
45。[Example 1] Toothpaste ingredients Weight % Aluminum hydroxide 40.0 Silicic acid anhydride 2.0 Propylene glycol 3.0 Sorbiturate solution 15.0 Glycerin 15.0 Sodium alginate 1.0 Saccharin sodium 0.2 Glucose 6-monolaurate 1.5N-sodium lauroylglutamate 0.5Fragrance
10 Preservatives Trace amount 100.0 [Example 2] Toothpaste ingredients Aluminosilicate Glycerin Sorbitol liquid Polyethylene glycol 400 Sodium carboxymethylcellulose Saccharin Sodium Glucose-6-monocaprate N-Lauroylsarcosine Sodium Flavor Color Plain purified water [Example 3 ] Toothpaste calcium carbonate (heavy) Calcium acid acid (light) Propylene glycol sorbitol liquid weight% 20, 0 15.0 40.0 4.0 1.2 0.2 1.0 0.5 1.0 Trace amount remaining Amount 30° 15° 3° 30° Sodium carboxymethylcellulose Saccharin Sodium Glucose tranexamate N-Myristoylmethyl-β-alanine Sodium Flavor Preservative 1.0 Trace glucose-6-monocaprylate N-Lauroylsarcosine Sodium allantoin chlorhydroxyaluminum flavor preservative [Example 5] Toothpaste 1.0 0.5 0, 1 1.0 Trace amount [Example 4] Toothpaste ingredients dibasic phosphate silicate anhydrous aluminum oxide propylene glycol sorbitol liquid carboxy Methyl cellulose sodium carrageenan saccharin sodium weight 45.
3。3.
1。1.
6 25。6 25.
O。O.
0。0.
0。0.
ジルコノシリケート
無水ケイ酸
ポリエチレングリコール400
ソルビット液
カルボキシメチルセルロースナトリウムサッカリンナト
リウム
グルコース−6−モノカプリレート
N−ラウロイルメチル−β−アラニン
ナトリウム
β−グリチルレチン酸
酢酸トコフェロール
0、01
0、1
香 料
色 素
1、0
微量
〔実施例6〕 潤製歯磨
成分
第2リン酸カルシウム
炭酸カルシウム
グリセリン
カルボキシメチルセルロースナトリウムサッカリンナト
リウム
グルコース−6−モノラウレート
N−ミリストイルザルコシンナトリウム香 料
重量
35。Zirconosilicate Polyethylene glycol silicic acid anhydride 400 Sorbitol solution Sodium carboxymethyl cellulose Sodium saccharin Glucose-6-monocaprylate Sodium N-lauroylmethyl-β-alanine β-Glycyrrhetinic acid Tocopheryl acetate 0,01 0,1 Fragrance color 1,0 Trace amount [Example 6] Moisturizing toothpaste ingredient dibasic calcium phosphate calcium carbonate glycerin carboxymethyl cellulose sodium saccharin sodium glucose-6-monolaurate N-myristoyl sarcosine sodium fragrance Weight 35.
40。40.
10。10.
0。0.
0。0.
1。1.
0。0.
1。1.
グリセリン ソルビット液 クエン酸 クエン酸ナトリウム サッカリンナトリウム グルコース−6−モノカプリレート Nーラウロイザルコシンナトリウム 香 料glycerin sorbitol liquid citric acid sodium citrate saccharin sodium Glucose-6-monocaprylate N-lauroysarcosine sodium fragrance
Claims (1)
酸塩と、アシル基の炭素数が8〜14であるグルコース
脂肪酸エステルとを併用してなることを特徴とする口腔
用組成物。1. An oral cavity composition comprising a combination of an N-acylamino acid salt and a glucose fatty acid ester whose acyl group has 8 to 14 carbon atoms in an amount of 0.5% by weight or less based on the total composition.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP34170489A JPH03200714A (en) | 1989-12-27 | 1989-12-27 | Composition for oral cavity application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP34170489A JPH03200714A (en) | 1989-12-27 | 1989-12-27 | Composition for oral cavity application |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH03200714A true JPH03200714A (en) | 1991-09-02 |
Family
ID=18348134
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP34170489A Pending JPH03200714A (en) | 1989-12-27 | 1989-12-27 | Composition for oral cavity application |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH03200714A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5286480A (en) * | 1992-06-29 | 1994-02-15 | The Procter & Gamble Company | Use of N-acetylated amino acid complexes in oral care compositions |
WO2013183748A1 (en) | 2012-06-08 | 2013-12-12 | 花王株式会社 | Oral composition |
JP2013253064A (en) * | 2012-06-08 | 2013-12-19 | Kao Corp | Toothpaste composition |
CN104363881A (en) * | 2012-05-28 | 2015-02-18 | 狮王株式会社 | Liquid oral composition |
JP2018090499A (en) * | 2016-11-30 | 2018-06-14 | ライオン株式会社 | Liquid denture detergent composition |
-
1989
- 1989-12-27 JP JP34170489A patent/JPH03200714A/en active Pending
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5286480A (en) * | 1992-06-29 | 1994-02-15 | The Procter & Gamble Company | Use of N-acetylated amino acid complexes in oral care compositions |
US5358705A (en) * | 1992-06-29 | 1994-10-25 | The Procter & Gamble Company | Use of N-acetylated amino acid complexes in oral care compositions |
CN104363881A (en) * | 2012-05-28 | 2015-02-18 | 狮王株式会社 | Liquid oral composition |
WO2013183748A1 (en) | 2012-06-08 | 2013-12-12 | 花王株式会社 | Oral composition |
JP2013253064A (en) * | 2012-06-08 | 2013-12-19 | Kao Corp | Toothpaste composition |
US9211241B2 (en) | 2012-06-08 | 2015-12-15 | Kao Corporation | Oral composition |
JP2018090499A (en) * | 2016-11-30 | 2018-06-14 | ライオン株式会社 | Liquid denture detergent composition |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2845245B2 (en) | Toothpaste composition | |
US4279888A (en) | Oral composition | |
JPS6234011B2 (en) | ||
JPH085773B2 (en) | Oral composition | |
JPH03200714A (en) | Composition for oral cavity application | |
JP2586896B2 (en) | Oral composition | |
JP2003104858A (en) | Composition for oral cavity | |
GB2073019A (en) | Oral compositions containing tranexamic acid | |
US3981989A (en) | Oral preparation | |
JPH07187977A (en) | Composition for oral cavity | |
JP2610444B2 (en) | Oral composition | |
JP2001172146A (en) | Composition for oral cavity | |
JPS5929612A (en) | Composition for oral cavity | |
US5017364A (en) | Paste-like dentifrice composition | |
JP2806029B2 (en) | Oral composition | |
JPH03223209A (en) | Composition for oral cavity application | |
JPH03200715A (en) | Composition for oral cavity application | |
JP2010143842A (en) | Dentifrice composition | |
JPS603285B2 (en) | Oral composition | |
JP2854114B2 (en) | Oral composition | |
JPH03200713A (en) | Composition for oral cavity application | |
JP7630247B2 (en) | Dentifrice Composition | |
JPS58225007A (en) | Composition for oral cavity | |
JP2973505B2 (en) | Oral composition | |
JPS58118506A (en) | Composition for oral cavity |